TickerFacts.

Fortrea Holdings Inc. (FTRE): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$88.30M
Year ended 2025-12-31
$196.00M
Trailing 12 months to 2026-06-30
+46.1%
3-year compound annual growth
$237.30M2021-12-31: $143.30M2022-12-31: $28.30M2023-12-31: $128.10M2024-12-31: $237.30M2025-12-31: $88.30M$88.30M
2021-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31$88.30M-62.8%2026-02-26, From 2025-01-01
2024-12-31$237.30M+85.2%2026-02-26, From 2024-01-01
2023-12-31$128.10M+352.7%2026-02-26, From 2023-01-01
2022-12-31$28.30Mn/c2025-03-03, From 2022-01-01
2021-12-31$143.30Mn/a2024-03-13, From 2021-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Fortrea Holdings Inc. (FTRE)2025-12-31$88.30M-62.8%
Natera, Inc. (NTRA)2025-12-31$109.11M+57.6%
Guardant Health, Inc. (GH)2025-12-31-$233.07Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$66.89Mn/m
Quest Diagnostics Inc (DGX)2025-12-31$1.36B+49.5%
Labcorp Holdings Inc. (LH)2025-12-31$1.21B+10.0%
Veracyte, Inc. (VCYT)2025-12-31$126.63M+98.5%
Castle Biosciences Inc (CSTL)2025-12-31$28.33M-22.5%
Fulgent Genetics, Inc. (FLGT)2025-12-31-$124.21Mn/m

Compare FTRE, NTRA, GH, CAI side by side · Screen every company in Services-Medical Laboratories ↗